AppointmentsNew Communications Director At The Cannabis Trades Association

New Communications Director At The Cannabis Trades Association

-

ONE of the founder members of the Cannabis Trades Association (CTA) has been appointed as its new Communications Director. 

Tim Henley says he is a committed evangelist to the whole-plant cannabis economy.

Tim Henley, a founder member of the Cannabis Trades Association.

He started as an entrepreneur in the first days of the legal industry and went on to work for one of the major global cannabis companies. 

He says he is delighted to accept the new position: “The UK is at a crossroads like no other we have seen.

“The UK has chosen to set itself up as in independent trading nation capable of setting its own rules and generating new prosperity from the change in regulatory regimes. 

“We are also in the midst of the most disruptive pandemics to sweep the globe in the last century.

“Our mission at the CTA is clear; to create simple, understandable messaging that amplifies across today’s multitude of echo-chambers to bring cannabis out of the closet.

“The industrialisation of society has led many of us to look for synthetic and sanitised versions of the natural world. This cannot go on and we need to go back to nature to find solutions for the current situation. 

“Cannabis is a medicine, it is a food source packed full of essential dietary elements, it is an industrial raw material, a natural carbon capture system that can remediate soils. 

“It has all the X Factor needed to make it a true star of the next decade.” 

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you